Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. M. Tariq, P. Kanthapillai, F. Parkar (Luton, United Kingdom). Finding asthmatics suitable for omalizumab therapy in a district hospital. Eur Respir J 2013; 42: Suppl. 57, 2025

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 A case diagnoed ACOS with omelizumab treatment Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Serious asthma exacerbations in a hospital setting Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Prevalence of asthma symptoms, diagnosis and treatment use in Romania Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Guideline adherence and cost of asthma treatment at emergency department Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Management of asthma in patients discharged from A and E Source: International Congress 2016 – Asthma points to ponder Year: 2016 Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies Source: International Congress 2014 – More paediatric asthma Year: 2014 Determinants of non-adherence to pharmacologic allergic rhinitis treatment Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Acute exacerbations of asthma in Barcelona, the recent experience Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 The asthma-COPD, overlap syndrome, our clinical experience Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014